Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses.
作者信息
Shamabadi Ahmad, Akhondzadeh Shahin
机构信息
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Avicenna J Med Biotechnol. 2022 Apr-Jun;14(2):102-103. doi: 10.18502/ajmb.v14i2.8881.
Abstract
摘要
相似文献
1
Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses.伊朗奥密克戎疫情中的新冠病毒疫苗接种与死亡率：致病性减弱和加强疫苗剂量导致的死亡率降低
Avicenna J Med Biotechnol. 2022 Apr-Jun;14(2):102-103. doi: 10.18502/ajmb.v14i2.8881.
2
Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.妊娠期 2019 年冠状病毒病（COVID-19）疫苗接种、严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染史和疫苗加强剂与分娩时母婴抗体水平的关系。
Obstet Gynecol. 2022 Mar 1;139(3):373-380. doi: 10.1097/AOG.0000000000004693.
3
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.COVID-19 相关住院病例在 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的种族/民族差异和疫苗接种状况分析——COVID-NET，14 个州，2021 年 7 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473. doi: 10.15585/mmwr.mm7112e2.
4
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.科兴新冠疫苗第三针诱导广泛而有效的适应性免疫应答，能识别 SARS-CoV-2 德尔塔和奥密克戎变异株。
Emerg Microbes Infect. 2022 Dec;11(1):1524-1536. doi: 10.1080/22221751.2022.2081614.
5
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.奥密克戎变异株广泛传播期间，养老院居民接种 COVID-19 追加初级或加强疫苗剂量对预防 SARS-CoV-2 感染的效果-美国，2022 年 2 月 14 日-3 月 27 日。
MMWR Morb Mortal Wkly Rep. 2022 May 6;71(18):633-637. doi: 10.15585/mmwr.mm7118a4.
6
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years.BNT162b2疫苗加强针在疗养院居民中针对新冠病毒德尔塔和奥密克戎变异株的免疫原性：一项针对68至98岁老年人的前瞻性观察研究。
Lancet Reg Health Eur. 2022 Jun;17:100385. doi: 10.1016/j.lanepe.2022.100385. Epub 2022 Apr 21.
7
BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients.BNT162b2加强疫苗接种在血液透析患者中诱导针对新冠病毒变异株的免疫力
Vaccines (Basel). 2022 Jun 17;10(6):967. doi: 10.3390/vaccines10060967.
8
Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.接种 BNT162b2 加强针后对 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 的血清中和作用。
Emerg Infect Dis. 2022 Jun;28(6):1274-1275. doi: 10.3201/eid2806.220503. Epub 2022 Mar 31.
9
Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?意大利南部接种过加强针（3剂）的医护人员中出现的新冠病毒奥密克戎变异株本土疫情：只是冰山一角？
Vaccines (Basel). 2022 Feb 13;10(2):283. doi: 10.3390/vaccines10020283.
10
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.评估 2 至 3 剂 BNT162b2 mRNA COVID-19 疫苗后针对 SARS-CoV-2 变异株的中和抗体反应。
JAMA Netw Open. 2022 May 2;5(5):e2210780. doi: 10.1001/jamanetworkopen.2022.10780.
引用本文的文献
1
The association of COVID- 19 parental immunization and transmission of disease to offspring: a retrospective study.新冠病毒肺炎父母免疫接种与疾病传播给后代的关联：一项回顾性研究
Ital J Pediatr. 2025 Apr 30;51(1):131. doi: 10.1186/s13052-025-01948-2.
2
Multilayer factors associated with excess all-cause mortality during the omicron and non-omicron waves of the COVID-19 pandemic: time series analysis in 29 countries.与 COVID-19 大流行的奥密克戎和非奥密克戎波期间全因超额死亡率相关的多层因素：29 个国家的时间序列分析。
BMC Public Health. 2024 Feb 2;24(1):350. doi: 10.1186/s12889-024-17803-8.
3
Analysis of SARS-CoV-2 Cases, COVID-19 Outcomes and Vaccinations, during the Different SARS-CoV-2 Variants in Greece.希腊不同新冠病毒变异株期间的新冠病毒病例、新冠肺炎结局及疫苗接种情况分析
Vaccines (Basel). 2023 Jan 4;11(1):126. doi: 10.3390/vaccines11010126.
本文引用的文献
1
What the Omicron wave is revealing about human immunity.奥密克戎毒株浪潮揭示了人类免疫力的哪些情况。
Nature. 2022 Feb;602(7895):22-25. doi: 10.1038/d41586-022-00214-3.
2
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.奥密克戎变异株 B.1.1.529 对 SARS-CoV-2 的复制和致病性减弱。
Nature. 2022 Mar;603(7902):693-699. doi: 10.1038/s41586-022-04442-5. Epub 2022 Jan 21.
3
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.基于信使核糖核酸的新冠病毒疫苗加强针可诱导针对严重急性呼吸综合征冠状病毒2奥密克戎变种的中和免疫力。
Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6.
4
Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.奥密克戎（B.1.1.529）-关注变异株-分子特征和流行病学：简要综述。
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8019-8022. doi: 10.26355/eurrev_202112_27653.
5
Universal Coronavirus Vaccines - An Urgent Need.通用冠状病毒疫苗——迫切需求
N Engl J Med. 2022 Jan 27;386(4):297-299. doi: 10.1056/NEJMp2118468. Epub 2021 Dec 15.
Zotero 插件